Bruce Caswell Acquires 3,500 Shares of Maximus, Inc. (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMSGet Free Report) CEO Bruce Caswell purchased 3,500 shares of Maximus stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the transaction, the chief executive officer now owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Maximus Stock Down 0.2 %

MMS stock traded down $0.13 during mid-day trading on Wednesday, hitting $70.07. 1,073,975 shares of the company were exchanged, compared to its average volume of 438,459. The firm has a market cap of $4.22 billion, a P/E ratio of 14.01 and a beta of 0.73. Maximus, Inc. has a 1-year low of $69.72 and a 1-year high of $93.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The firm’s 50 day simple moving average is $81.37 and its 200 day simple moving average is $86.30.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date of this dividend was Friday, November 15th. Maximus’s payout ratio is presently 24.00%.

Institutional Trading of Maximus

A number of institutional investors have recently modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after buying an additional 292,300 shares in the last quarter. Versor Investments LP raised its stake in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after buying an additional 5,789 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after buying an additional 102,350 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of Maximus by 143.3% during the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider’s stock worth $5,538,000 after acquiring an additional 35,012 shares during the period. Finally, Algert Global LLC bought a new stake in Maximus in the 2nd quarter valued at $12,424,000. 97.21% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.

Read Our Latest Stock Analysis on Maximus

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.